DC Funds, LP TCRX Holdings History
Number of Shares
630,000.00
Current Holdings Value*
$869,400.00
% of Portfolio
42.07%
Total Estimate Gain
$-4.69 Mil
% of Total Estimate Gain
-80.45%
DC Funds, LP's TScan Therapeutics Inc Holding Summary
As of 2025-03-31, DC Funds, LP held 630,000.00 shares of TScan Therapeutics Inc(TCRX), totaling $869,400.00. This investment constitutes 42.07% of their stock portfolio, and DC Funds, LP now holds 1.11% of the outstanding TScan Therapeutics Inc(TCRX) stock.
The initial trade took place in 2021Q3. And since then DC Funds, LP has made 1 purchases of TCRX, at an average price of $9.26, for a total of 630,000.00 shares. Based on historical transaction data and TCRX's current price of $1.81, DC Funds, LP's estimated gain on his TCRX holdings is $-4.69 Mil, reflecting a -80.45% gain to date.
DC Funds, LP TCRX ($1.81) Holding Chart
DC Funds, LP TCRX ($1.81) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1